(3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one

C26H42O13 — CID 118247543

IUPAC(3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one
SMILESCC1O[C@@H](OC2[C@H](C)CCC[C@H]2O[C@@H]2OC(CO)[C@H](O)C3O[C@H]4C(=O)OC[C@@H]4CCCOC32)[C@@H](O)C(O)[C@@H]1O
InChIInChI=1S/C26H42O13/c1-11-5-3-7-14(20(11)39-25-19(31)18(30)16(28)12(2)35-25)36-26-23-22(17(29)15(9-27)37-26)38-21-13(6-4-8-33-23)10-34-24(21)32/h11-23,25-31H,3-10H2,1-2H3/t11-,12?,13+,14-,15?,16-,17+,18?,19+,20?,21-,22?,23?,25+,26-/m1/s1
InChIKeyXQKMJJODSREAEH-OVROFCCWSA-N
MW562.61 g/mol
LogP-1.41
Rot. Bonds5

About (3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one

(3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one (PubChem CID 118247543) has the molecular formula C26H42O13 and a molecular weight of 562.61 g/mol. Its IUPAC name is (3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one.

Molecular Properties

Compound Name(3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one
PubChem CID118247543
Molecular FormulaC26H42O13
Molecular Weight562.61 g/mol
Exact Mass562.26
IUPAC Name(3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one
SMILESCC1O[C@@H](OC2[C@H](C)CCC[C@H]2O[C@@H]2OC(CO)[C@H](O)C3O[C@H]4C(=O)OC[C@@H]4CCCOC32)[C@@H](O)C(O)[C@@H]1O
InChIInChI=1S/C26H42O13/c1-11-5-3-7-14(20(11)39-25-19(31)18(30)16(28)12(2)35-25)36-26-23-22(17(29)15(9-27)37-26)38-21-13(6-4-8-33-23)10-34-24(21)32/h11-23,25-31H,3-10H2,1-2H3/t11-,12?,13+,14-,15?,16-,17+,18?,19+,20?,21-,22?,23?,25+,26-/m1/s1
InChIKeyXQKMJJODSREAEH-OVROFCCWSA-N
XLogP-1.41
TPSA182.83 Ų
H-Bond Donors5
H-Bond Acceptors13
Rotatable Bonds5
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500562.61
LogP ≤ 5-1.41
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1013

Analyze (3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one?
The IUPAC name of (3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one (CID 118247543) is (3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one.
What is the SMILES notation for (3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one?
The canonical SMILES for (3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one is CC1O[C@@H](OC2[C@H](C)CCC[C@H]2O[C@@H]2OC(CO)[C@H](O)C3O[C@H]4C(=O)OC[C@@H]4CCCOC32)[C@@H](O)C(O)[C@@H]1O.
What is the InChIKey of (3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one?
The InChIKey is XQKMJJODSREAEH-OVROFCCWSA-N. The full InChI is InChI=1S/C26H42O13/c1-11-5-3-7-14(20(11)39-25-19(31)18(30)16(28)12(2)35-25)36-26-23-22(17(29)15(9-27)37-26)38-21-13(6-4-8-33-23)10-34-24(21)32/h11-23,25-31H,3-10H2,1-2H3/t11-,12?,13+,14-,15?,16-,17+,18?,19+,20?,21-,22?,23?,25+,26-/m1/s1.
What are the key properties of (3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one?
(3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one has a molecular weight of 562.61 g/mol, XLogP of -1.41, 5 rotatable bonds, 5 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (3R,7S,13R,16S)-16-hydroxy-15-(hydroxymethyl)-13-[(1R,3R)-3-methyl-2-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-2,5,11,14-tetraoxatricyclo[10.4.0.03,7]hexadecan-4-one is sourced from PubChem (CID 118247543), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).